ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2322

Dynamic Regulation of T Follicular Helper Cell Differentiation Through STAT Signaling

Shingo Nakayamada1, Yuka Kanno2, Golnaz Vahedi2, John J. O'Shea2 and Yoshiya Tanaka1, 1First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines and signal transduction, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: T follicular helper (Tfh) cells are a new subset of T cells that regulate B cell function and exert an important role in the pathogenesis of autoimmune diseases. However, their relationship with other helper lineages and the mechanisms that direct their specification are incompletely understood. As STAT family transcription factors play pivotal roles in specifying T cell lineages, we investigated the roles of STAT proteins in Tfh cell differentiation.

Methods: Naive CD4+ T cells isolated from wild type and STAT deficient mice were activated and cultured with various cytokines. Cytokine production and expression of cell surface molecules and transcription factors were assessed by flow cytometry and qPCR. Genome-wide targets of STATs and epigenetic modifications in Tfh-like cells were evaluated by chromatin immunoprecipitation sequencing (ChIP-seq) and DNaseI hypersensitivity sequencing (DNase-seq). Expression levels of mRNA were determined by microarray analysis.

Results: IL-12 acting STAT4 directly induced IL-21- and IFN-γ-producing cells, which share features of both Tfh and Th1 cells. Although IL-4 acting STAT6 had no effect for induction of IL-21 and IFN-g, IL-6 acting STAT3 generated cells that express IL-21 and not IFN-g. STAT4-indued IL-21 in turn acted through STAT3 in a positive feedback loop to maximize IL-21 production. Using ChIP-seq and DNase-seq, we found that both STAT3 and STAT4 directly bound to multiple genes involved in Tfh cell development including Il21 and Bcl6, regulating gene expression and epigenetic modifications. Thus, STAT3 and STAT4 redundantly serve to induce IL-21, Bcl6 and other Tfh cell molecules. However, STAT4 also induced the transcription factor T-bet that repressed Bcl6, thereby attenuating the Tfh-like phenotype. IFN-γ-dependent activation of STAT1 induced T-bet, which produced a biphasic effect: early on it promotes, but later it inhibits, Tfh-like phenotype. Finally, the Bcl6 locus remained accessible in fully polarized effector T cells, suggesting that although Bcl6 expression can vary with different states of differentiation; this locus remains poised for transcription even in the absence of active transcription.

Conclusion: These results highlight the importance of STAT-mediated gene regulation, which underlies plasticity of Tfh cells. Like Th17 cells, Tfh cells are a fluid subset and their differentiation represents a dynamic balance of signals mediated by STATs. Thus, modulation of STAT-mediated gene regulation in Tfh cells should offer opportunities for the treatment of autoimmune diseases.


Disclosure:

S. Nakayamada,
None;

Y. Kanno,
None;

G. Vahedi,
None;

J. J. O’Shea,
None;

Y. Tanaka,

Bristol-Myers Squibb KK,

2,

MSD KK,

2,

Chugai Pharmaceutical ,

2,

Mitsubishi Tanabe Pharma,

2,

Astellas Pharma ,

2,

Abbot Japan ,

2,

Eisai,

2,

Janssen Pharmaceutical KK,

2,

Mitsubishi Tanabe Pharma ,

8,

Abbot Japan ,

8,

Chugai Pharmaceutical ,

8,

Janssen Pharmaceutica KK,

8,

Santen Pharmaceutical ,

8,

Pfizer Japan ,

8,

Astellas Pharma ,

8,

Daiichi Sankyo ,

8.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dynamic-regulation-of-t-follicular-helper-cell-differentiation-through-stat-signaling/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology